Kymera Therapeutics has been granted a patent for compounds and methods targeting protein degradation for treating protein-mediated disorders. The invention involves administering specific compounds to patients for effective treatment. GlobalData’s report on Kymera Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Kymera Therapeutics, Nanoparticle drug conjugates was a key innovation area identified from patents. Kymera Therapeutics's grant share as of May 2024 was 2%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US12006329B2) discloses a method for treating target protein-mediated disorders, diseases, or conditions in patients by administering a compound of Formula II-b'?. The method covers a wide range of disorders including various types of carcinomas such as squamous-cell carcinoma, basal cell carcinoma, adenocarcinoma, and hepatocellular carcinomas, as well as different forms of lymphomas, sarcomas, and leukemia.
The patent further details the specific chemical structure of the compound, with each R1 and R2 group being independently selected from various substituents, and L2 being a bivalent hydrocarbon chain with specific modifications. Additionally, Ring B in the compound can be selected from different aryl or heteroaryl groups. The method also specifies the particular disorders that can be targeted, including leukemias, lymphomas, and sarcomas, expanding the potential applications of the disclosed compound in the treatment of these conditions.
To know more about GlobalData’s detailed insights on Kymera Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
